Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald F Watts

Showing results (611-620 of 706) with videos related to

Pageof 71
Sort By:
Australian Journal of General Practice|August 31, 2021
Awareness of familial hypercholesterolaemia in Australian primary care: A qualitative descriptive studyCaroline Bulsara, Tom Brett, Jan Radford, et al.
Circulation. Genomic and Precision Medicine|June 12, 2020
Familial Hypercholesterolemia in a Healthy Elderly PopulationPaul Lacaze, Robert Sebra, Moeen Riaz, et al.
Pharmacological Research|July 21, 2015
Statin therapy and plasma coenzyme Q10 concentrations--A systematic review and meta-analysis of placebo-controlled trialsMaciej Banach, Corina Serban, Sorin Ursoniu, et al.
Nature Medicine|April 7, 2026
Zodasiran for cholesterol and triglyceride lowering in patients with hyperlipidemia: final report of phase 1 basket trialGerald F Watts, Russell Scott, David Sullivan, et al.
Australian Journal of General Practice|July 31, 2022
Cost impact of undertaking detection and management of familial hypercholesterolaemia in Australian general practiceIan W Li, Rory Watts, Tom Brett, et al.
Atherosclerosis|July 18, 2015
Tibolone decreases Lipoprotein(a) levels in postmenopausal women: A systematic review and meta-analysis of 12 studies with 1009 patientsKazuhiko Kotani, Amirhossein Sahebkar, Corina Serban, et al.
Atherosclerosis|December 25, 2016
Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control studySven Bos, Martijne H C Duvekot, Gert-Jan R Ten Kate, et al.
The Lancet. Diabetes & Endocrinology|February 21, 2017
Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG studyFrederick J Raal, G Kees Hovingh, Dirk Blom, et al.
American Journal of Preventive Cardiology|June 15, 2026
Use of plozasiran across a spectrum of hypertriglyceridemia: Long-term efficacy and safety data from the open-label extension period of SHASTA-2 and MUIR TrialsChristie M Ballantyne, Alexis Baass, Robert S Rosenson, et al.
Atherosclerosis|October 20, 2023
Long-term outcomes of liver transplantation for homozygous familial hypercholesterolaemia in Australia and New ZealandMichael M Page, Winita Hardikar, George Alex, et al.
Pageof 71

Showing results (611-620 of 706) with videos related to

Sort By:
Pageof 71
Australian Journal of General Practice|August 31, 2021
Awareness of familial hypercholesterolaemia in Australian primary care: A qualitative descriptive studyCaroline Bulsara, Tom Brett, Jan Radford, et al.
Circulation. Genomic and Precision Medicine|June 12, 2020
Familial Hypercholesterolemia in a Healthy Elderly PopulationPaul Lacaze, Robert Sebra, Moeen Riaz, et al.
Pharmacological Research|July 21, 2015
Statin therapy and plasma coenzyme Q10 concentrations--A systematic review and meta-analysis of placebo-controlled trialsMaciej Banach, Corina Serban, Sorin Ursoniu, et al.
Nature Medicine|April 7, 2026
Zodasiran for cholesterol and triglyceride lowering in patients with hyperlipidemia: final report of phase 1 basket trialGerald F Watts, Russell Scott, David Sullivan, et al.
Australian Journal of General Practice|July 31, 2022
Cost impact of undertaking detection and management of familial hypercholesterolaemia in Australian general practiceIan W Li, Rory Watts, Tom Brett, et al.
Atherosclerosis|July 18, 2015
Tibolone decreases Lipoprotein(a) levels in postmenopausal women: A systematic review and meta-analysis of 12 studies with 1009 patientsKazuhiko Kotani, Amirhossein Sahebkar, Corina Serban, et al.
Atherosclerosis|December 25, 2016
Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control studySven Bos, Martijne H C Duvekot, Gert-Jan R Ten Kate, et al.
The Lancet. Diabetes & Endocrinology|February 21, 2017
Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG studyFrederick J Raal, G Kees Hovingh, Dirk Blom, et al.
American Journal of Preventive Cardiology|June 15, 2026
Use of plozasiran across a spectrum of hypertriglyceridemia: Long-term efficacy and safety data from the open-label extension period of SHASTA-2 and MUIR TrialsChristie M Ballantyne, Alexis Baass, Robert S Rosenson, et al.
Atherosclerosis|October 20, 2023
Long-term outcomes of liver transplantation for homozygous familial hypercholesterolaemia in Australia and New ZealandMichael M Page, Winita Hardikar, George Alex, et al.
Pageof 71